NA
Navidea Biopharmaceuticals, Inc.
NAVBQ · OTC
$0.00 +0.00% (+$0.00)
1M +0.00%
Market Cap $10.0K
P/E Ratio -
Div. Yield -
ROE -
Piotroski F-Score Weak
2/9Valuation
100 /100
Cheap P/S 0.15x
PEG N/A
P/B N/A
Growth
100 /100
Growing Rev. growth 35.11%
FCF growth N/A
Book val. growth N/A
Profitability
0 /100
Weak Net margin 23,117.60%
Op. margin 21,402.10%
FCF margin 14,282.80%
Quality
57 /100
Average ROA 347.18%
Asset turnover 0.02x
ROIC 280.59%
Debt
50 /100
Moderate Int. coverage -12.82x
Net debt/EBITDA -0.03x
Current ratio 0.32x
Stability
28 /100
Unstable Rev. volatility 1,964.48%
EPS volatility 39.84%
Profitable years 0
Bulios Scoring opisuje jakość i historię firmy, a nie przyszły zwrot. Wysoki wynik to nie sygnał zakupu. Dowiedz się więcej
Zapytaj StockBota o NAVBQ
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Craig A. Dais
Employees
11
Headquarters
Dublin
Nadchodzące wydarzenia
16 LIS
Earnings
Upcoming earnings report